A new trading day began on Friday, with Exact Sciences Corp (NASDAQ: EXAS) stock price up 3.55% from the previous day of trading, before settling in for the closing price of $51.81. EXAS’s price has ranged from $39.97 to $72.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -54.24% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 90.85%. With a float of $185.74 million, this company’s outstanding shares have now reached $188.59 million.
In an organization with 7000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 68.19%, operating margin of -36.55%, and the pretax margin is -36.39%.
Exact Sciences Corp (EXAS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Exact Sciences Corp is 1.54%, while institutional ownership is 97.62%. The most recent insider transaction that took place on Jun 13 ’25, was worth 170,612. In this transaction Director of this company sold 3,207 shares at a rate of $53.20, taking the stock ownership to the 72,759 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director proposed sale 3,207 for $53.20, making the entire transaction worth $170,612.
Exact Sciences Corp (EXAS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 90.85% per share during the next fiscal year.
Exact Sciences Corp (NASDAQ: EXAS) Trading Performance Indicators
Here are Exact Sciences Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.58. Likewise, its price to free cash flow for the trailing twelve months is 52.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.50, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Exact Sciences Corp (EXAS)
Let’s dig in a bit further. During the last 5-days, its volume was 3.98 million. That was better than the volume of 2.67 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 40.47%.
During the past 100 days, Exact Sciences Corp’s (EXAS) raw stochastic average was set at 73.12%, which indicates a significant increase from 48.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.32% in the past 14 days, which was lower than the 44.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $52.32, while its 200-day Moving Average is $55.65. However, in the short run, Exact Sciences Corp’s stock first resistance to watch stands at $57.30. Second resistance stands at $60.96. The third major resistance level sits at $64.51. If the price goes on to break the first support level at $50.09, it is likely to go to the next support level at $46.54. The third support level lies at $42.88 if the price breaches the second support level.
Exact Sciences Corp (NASDAQ: EXAS) Key Stats
With a market capitalization of 10.12 billion, the company has a total of 188,638K Shares Outstanding. Currently, annual sales are 2,759 M while annual income is -1,029 M. The company’s previous quarter sales were 706,790 K while its latest quarter income was -101,220 K.
